The Patterson Analysis

The digital health startup ranked in the top 100 for its revolutionary AI platform that tackles the silent, global threat of chronic kidney disease.

Celebrating its public listing, Our Bond, Inc. highlights its mission to redefine safety with a preventative AI platform already used by global giants.

With a new CFO from Angi, TouchTunes is unifying music, darts, and payments into a connected social ecosystem, signaling a new era of growth.

After revolutionizing cat treats with Churu, Inaba is launching Churu Terrine for dogs, a move poised to shake up the multi-billion dollar canine market.

60 Teamsters launch a ULP strike against a packaging giant, demanding fair wages and threatening the supply chain for Domino's and Papa John's.

Nucleus Research's 2026 report reveals a mature RPA market where AI-driven 'agentic automation' and measurable ROI are now the gold standard.

Retargeting costs surge 18% as advertisers chase ROI, fleeing declining web traffic and moving top-funnel budgets to connected TV and digital billboards.

GuideWell's 2025 Impact Report details a multi-pronged strategy using AI, community investment, and value-based care to tackle healthcare costs.

As the Pentagon accelerates its AI push, Striveworks lands key funding to expand its AIOps platform, aiming to deliver fast, trusted AI to the front lines.

Airport operator GAP secures independent verification for its 25% emissions cut, a key win for its green bonds and the fight against greenwashing.

Inspira Enterprise joins the exclusive Microsoft Intelligent Security Association, signaling a deeper push for integrated, AI-driven cybersecurity solutions.

Facing a $35.7M loss and crippling 45% tariffs, Conifex Timber secures a lifeline loan while warning it may not survive the ongoing trade war.

With key trial enrollment complete, Pyxis Oncology refines its cancer drug MICVO for safety and prepares for pivotal data under a new, seasoned CEO.

A new one-hour test for sepsis could change critical care, offering rapid results that help doctors fight the clock and save lives. Here's how it works.

New study shows AI can match invasive methods for plaque analysis, a major step towards non-invasively predicting and preventing heart attacks.

The pharma giant is acquiring a promising 'best-in-class' PI3Kα inhibitor, SNV4818, in a move to bolster its oncology pipeline and redefine cancer care.

Biotech firm Ribo Life Science reveals a new platform targeting the kidney, heart, and fat tissue, signaling a major shift for RNA-based medicines.

New federal and state laws aim to rein in PBMs, but experts warn that without continuous monitoring, these reforms may create more problems than they solve.

With record attendance and a new Silicon Valley venue, the premier verification conference zeroed in on AI as the key to solving chip design's biggest bottleneck.

A senior-focused healthcare provider achieves a 95.5% automation rate and a $35M revenue boost by deploying an autonomous medical coding AI platform.